WPD Pharmaceuticals Inc.
WBIO
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.90K | 2.20K | 8.00K | 65.00K | 106.00K |
| Total Receivables | 32.70K | 30.80K | 27.60K | 24.70K | 44.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.60K | 2.60K | 2.60K | 2.70K | 8.10K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 42.20K | 35.60K | 38.20K | 92.30K | 158.20K |
|
|
|||||
| Total Current Assets | 42.20K | 35.60K | 38.20K | 92.30K | 158.20K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 216.50K | 199.60K | 204.00K | 262.30K | 158.20K |
|
|
|||||
| Total Accounts Payable | 340.00K | 407.20K | 448.50K | 403.50K | 360.80K |
| Total Accrued Expenses | 30.40K | 25.20K | 32.70K | 37.50K | 72.10K |
| Short-term Debt | 15.20K | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 17.40K | 11.80K | 11.90K | 12.20K | 12.00K |
| Total Other Current Liabilities | 17.40K | 11.80K | 11.90K | 12.20K | 12.00K |
| Total Current Liabilities | 403.00K | 444.20K | 493.20K | 453.20K | 444.80K |
|
|
|||||
| Total Current Liabilities | 403.00K | 444.20K | 493.20K | 453.20K | 444.80K |
| Long-Term Debt | 274.20K | 249.00K | 237.80K | 230.10K | 209.40K |
| Short-term Debt | 15.20K | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 677.20K | 693.20K | 730.90K | 683.30K | 654.20K |
|
|
|||||
| Common Stock & APIC | 12.69M | 12.52M | 12.62M | 12.94M | 12.63M |
| Retained Earnings | -16.39M | -16.21M | -16.37M | -16.67M | -16.36M |
| Treasury Stock & Other | 3.24M | 3.20M | 3.23M | 3.31M | 3.24M |
| Total Common Equity | -460.60K | -493.70K | -527.00K | -421.00K | -496.10K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -460.60K | -493.70K | -527.00K | -421.00K | -496.10K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -460.60K | -493.70K | -527.00K | -421.00K | -496.10K |
|
|
|||||
